In this study, we have successfully employed a combination of 3D-QSAR modeling, molecular docking, and molecular dynamics simulations to design and screen novel 1,2,4-Triazole-3-thione derivatives as potential inhibitors of DCN1 for the treatment of anticardiac fibrosis. The gene discussed is DCUN1D1; the disease is fibrosis.